p53 Abnormalities in Different Subtypes of Human Sarcomas

Cancer Research

Volumn 53, Issue 3, 1993, Pages 468-471

  H⊘ie, J ^b   Myklebost, O ^a   Hovig, E ^a   Holm, R ^a   Fl⊘renes, V A ^a   Bruland, O S ^a   Fodstad, O ^a  

^a INSTITUTE OF CANCER RESEARCH   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; CANCER CLASSIFICATION; CARCINOGENESIS; CHROMOSOME 17; EXON; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LEIOMYOSARCOMA; MALIGNANT FIBROUS HISTIOCYTOMA; NORTHERN BLOTTING; OSTEOSARCOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SOFT TISSUE TUMOR; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; DNA, NEOPLASM; EXONS; GENE EXPRESSION; GENES, P53; HETEROZYGOTE; HUMAN; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN P53; RNA, MESSENGER; SARCOMA; SUPPORT, NON-U.S. GOV'T;

EID: 0027464950     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Newton, W. A. J. Meadows, A. T. Shimada, H. Bunin, G. R. and Vawter, G. F. Bone sarcomas as second malignant neoplasms following childhood cancer. Cancer (Phila.), 67: 193-201, 1991.
2. Friend, S. H. Bernards, R. Rogelj, S. Weinberg, R. A. Rapaport, J. M. Albeit, D. M. and Dryja, T. P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (Lond.), 323: 643-646, 1986.
3. Shew, J.-Y. Ling, N. Mendoza, A. E. Fodstad, O. and Lee, W-H. Antibodies to the retinoblastoma gene product detect specific loss of pp110RB in osteosarcomas and synovial sarcomas. Oncogene Res. 1: 20S-214, 1989.
4. Stratton, M. R. Moss, S. Warren, W. Patterson, H. Clark, J. Fisher, C. Fletcher, C. D. M. Ball, A. Thomas, M. Gusterson, B. A. and Cooper, C. S. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RBI gene. Oncogene, 5: 1297-1301, 1990.
5. Nigra, J. M. Baker, S. J. Preisinger, A. C. Jessup, J. M. Hostetter, R. Cleary, K. Bigner, S. H. Davidson, N. Baylin, S. Devilee, P. Glover, T. Collins, F. S. Weston, A. Modali, R. Harris, C. C. and Vogelstein, B. Mutations in p53 gene occur in diverse human tumour types. Nature (Lond.), 342: 705-708, 1989.
6. Baker, S. J. Fearon, E. R. Nigra, J. M. Hamilton, S. R. Preisinger, A. C. Jessup, J. M. Van Tuinen, P. Ledbetter, D. H. Barker, D. F. Nakamura, Y. et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (Washington DC), 244: 217-221, 1989.
7. Takahashi, T. Natl. M. M. Chiba, I. Birrer, M. J. Rosenberg, R. K. Vinocour, M. Levitt, M. Pass, H. Gazdar, A. F. and Minna, J. D. p53: a frequent target for genetic abnormalities in lung cancer. Science (Washington DC), 246: 491-494, 1989.
8. Mulligan, L. M. Matlashewski, G. J. Scrable, H. J. and Cavenee, W. K. Mechanisms of p53 loss in human sarcomas. Proc. Natl. Acad. Sci. USA, 87: 5863-5867, 1990.
9. Miller, C. W. Aslo, A. Tsay, C. Slamon, D. Ishizaki, K. Toguchida, J. Yamamuro, T. Lampkin, B. and Koeffler, H. P. Frequency and structure of p53 rearrangements in human osteosarcoma. Cancer Res. 50: 7950-7954, 1990.
10. Masuda, H. Miller, C. Koeffler, H. P. Battifora, H. and Cline, M. J. Rearrangement of the p53 gene in human osteogenic sarcomas. Proc. Natl. Acad. Sci. USA, 84: 7716-7719, 1987.
11. Toguchida, J. Ishizaki, K. Nakamura, Y. Sasaki, M. S. Ikenaga, M. Kato, M. Sugimoto, M. Kotoura, Y. and Yamamuro, T. Assignment of common allele loss in osteosarcoma to the subregion 17pl3. Cancer Res. 49: 6247-6251, 1989.
12. Fodstad, O. Br0gger, A. Bruland, O. S. Solheim, O. P. Nesland, J. M. and Pihl, A. Characterisation of a cell line established from a patient with multiple osteosarcoma, appearing 13 years after treatment for bilateral retinoblastoma. Int. J. Cancer, 38: 33-40, 1986.
13. Church, G. M. and Gilbert, W. Genomic sequencing. Proc. Natl. Acad. Sci. USA, 81: 1991-1995, 1984.
14. Feinberg, A. P. and Vogelstein, B. A. technique for radiolabeling DNA restriction endonuclases fragments to high specific activity. Anal. Biochem. 132: 613-619, 1983.
15. Ara, S. Lee, P.S.Y., Hansen, M. F. and Saya, H. Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res. 18: 4961, 1990.
16. McDaniel, T, Carbone, D. Takahashi, T. Chumakov. Chang, E. H. Pirollo, K. F. Yin, J. Huang, Y. and Meltzer, S. J. The Mspl polymorphism in intron 6 of p53 (TP53) detected by digestion of PCR products. Nucleic Acids Res. 19: 47%, 1991.
17. Hovig, E. Smith-Sorensen, B. Brogger, A. and Borresen, A-L. Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation research. Mutat. Res. 267: 63-67, 1991.
18. Borresen, A.-L. Hovig, E. Smith-Sorensen, B. Malkin, D. Lystad, S. Andersen, T. I. Nesland, J. M. Isselbacher, K. J. and Friend, S. H. Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. Proc. Natl. Acad. Sci. USA, 88: 8405-8409, 1991.
19. Hultman, T. Stahl, S. Hornes, E. and Uhlen, M. Direct solid phase sequencing of genomic and plasmid DNA using magnetic beads as solid support. Nucleic Acids Res. 17: 4937, 1989.
20. Chomczynski, P. and Sacchi, N. Single-step method of RNA isolation by acid guanidinium-thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
21. Maniatis, T. Fritsh, E. F. and Sambrook, J. Molecular cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
22. Hsu, S.-M. Raine, L. and Fanger, H. Comparative study of the peroxidase-antiper-oxidase methode and an avidin-biotin complex methode for studying polypeptide hormones with radioimmunoassay antibodies. Am. J. Clin. Pathol. 75: 734-738, 1981.
23. Caron de Fromentel, C. and Soussi, T. TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer, 4: 1-15, 1992.
24. Coles, C. Thompson, A. M. Elder, P. A. Cohen, B. B. Mackenzie, I. M. Cranstone, G. Chetty, U. Mackay, J. Macdonald, M. Nakamura, Y. Hoyheim, B. and Steel, C. M. Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis. Lancet, 336: 761-763, 1990.
25. Thompson, A. M. Steel, C. M. Chetty, U. Hawkins, R. A. Miller, W. R. Carter, D. C. Forrest, A. P. M. and Evans, H. J. p53 gene mRNA expression and chromosome 17p allele loss on breast cancer. Br. J. Cancer, 61: 74-78, 1990.
26. Biegel, J. A. Burk, C. D. Barr, F. G. and Emanuel, B. S. Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res. 52: 3391-3395, 1992.
27. Farmer, G. Bargonetti, J. Zhu, H. Friedman, P. Prywes, R. and Prives, C. Wild-type p53 activates transcription in vitro. Nature (Lond.), 358: 83-86, 1992.
28. El-Deiry, W. S. Kern, S. E. Pietenpol, J. A. Kinzler, K. W. and Vogelstein, B. Definition of a consensus binding site for p53. Nature Genetics (Lond.), 1: 45-49, 1992.
29. Oliner, J. D. Kinzler, K. W. Meltzer, P. S. George, D. L. and Vogelstein, B. Amplification of a gene encoding a p55-associated protein in human sarcomas. Nature (Lond.), 358: 80-83, 1992.
30. Levine, A. The p53 tumor-suppressor gene. N. Engl. J. Med. 326: 1350-1352, 1992.
31. Maxwell, S. A. Ames, S. K. Sawai, E. T. Decker, G. L. Cook, R. G. and Butel, J. S. Simian virus 40 large T antigen and p53 are microtubule-associated proteins in transformed cells. Cell Growth & Differ. 2: 115-127, 1991.
32. Werness, B. A. Levine, A. J. and Howley, P. M. Association of human papillomavirus types 16 and 18E6 proteins with p53. Science (Washington DC), 248: 76-79, 1990.
33. Lane, D. P. p53, guardian of the genome. Nature (Lond.), 358: 15-16, 1992.
34. Vogelstein, B. and Kinzler, K. W. p53 function and dysfunction. Cell, 70: 523-526, 1992.
35. Hollstein, M. Sidransky, D. Vogelstein, B. and Harris, C. C. p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
36. Frebourg, T. Kassel, J. Lam, K. T. Gryka, M. A. Barbier, N. Andersen, T. I. Borresen, A.-L. and Friend, S. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein. Proc. Natl. Acad. Sci. USA, 89: 6413-6417, 1992.
37. Kondoleon, S. Vissing, H. Luo, X. Y. Magenis, R. E. Kellogg, J. and Litt, M. A. hypervariable RFLP on chromosome 17pl3 is defined by an arbitrary single copy probe pl44-D6. Nucleic Acids Res. 75: 10605, 1987.
38. Nakamura, Y. Leppert, M. O'Connell, P. Wolff, R. Holm, T. Culver, M’ Martin, C. Fujimoto, E. Hoff, M. Kumlin, E. and White, R. Variable number of tandem repeat (VNTR) markers of human gene mapping. Science (Washington DC), 235: 1616- 1622, 1987.
39. Zakut-Houri, R. Bienz-Tadmor, B. Givol, D. and Oren, M. Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells. EMBO J. 4: 1251- 1255, 1985.
40. Hoyheim, B. Nakamura, Y. and White, R. A. ZtomHI-polymorphism is detected by a genomic p53-clone. Nucleic Acids Res. 17: 8898, 1989.
41. Bartek, J. Bartkova, J. Vojtesek, B. Staskova, Z. Rejthar, A. Kovarik, J. and Lane, D. P. Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro. Int. J. Cancer, 46: 839-844, 1990.
42. Barker, D. Schafer, M. and White, R. Restriction sites containing CpG show a higher frequency of polymorphism in human DNA. Cell, 36: 131-138, 1984.
43. Barker, D. Wright, E. Nguyen, K. Cannon, L. Fain, P. Goldgar, D. Bishop, D. T. Carey, J. Baty, B. Kivlin, J. Willard, H. Waye, J. S. Greig, G. Leinwand, L. Nakamura, Y. O'Connell, P. Leppert, M. Lalouel, J.-M. White, R. and Skolnick, M. Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science (Washington DC), 236: 1100-1102, 1987.